Immunoglobulin prophylaxis in hematological malignancies and hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Immunoglobulin prophylaxis in hematological malignancies and hematopoietic stem cell transplantation

Published:2008-10-08 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Raanani Pia¹,Gafter-Gvili Anat²,Paul Mical³,Ben-Bassat Isaac⁴,Leibovici Leonard²,Shpilberg Ofer¹

Affiliation:

1. Rabin Medical Center; Institute of Hematology; Institute of Hematology, Rabin Medical Center, Campus Beilinson Petah-Tikva Israel 49100

2. Beilinson Campus, Rabin Medical Center; Department of Medicine E; Kaplan Petah-Tiqva Israel 49100

3. Rabin Medical Center; Infectious Diseases Unit and Department of Medicine E; Beilinson Campus Petah-Tikva Israel 49100

4. Sheba Medical Center, Tel-Hashomer; Institute of Hematology; Institute of Hematology, Sheba Medical Center Tel-Hashomer Israel 52621

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD006501.pub2/fullpdf

Reference105 articles.

1. Comparison of two doses of intravenous immunoglobulin after allogeneic bone marrow transplants;Abdel-Mageed;Bone marrow transplantation,1999

2. Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation;Boeckh;Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,2001

3. [Clinical and biological evaluation of the preventive role of anti-cytomegalovirus specific immunoglobulins in bone marrow grafts. Randomized study of 60 patients];Bordigoni;Nouvelle revue fran?aise d'hematologie,1987

4. Randomized trial of intravenous immunoglobulin prophylaxis for patients with chronic lymphocytic leukaemia and secondary hypogammaglobulinaemia;Boughton;Clinical and laboratory haematology,1995

5. ytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation;Bowden;The New England journal of medicine,1986

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between serum IgG concentrations and the incidence of infections in patients with chronic lymphocytic leukemia and secondary immunodeficiency under treatment with Privigen;Int. Journal of Clinical Pharmacology and Therapeutics;2024-06-01

2. Economic evaluation: immunoglobulin vs prophylactic antibiotics in hypogammaglobulinemia and hematological malignancies;Blood Advances;2024-05-14

3. Immunoglobulin replacement to prevent infections in people with haematological malignancies and haematopoietic stem cell transplantation;Cochrane Database of Systematic Reviews;2024-03-04

4. A systematic review of the cost and cost-effectiveness of immunoglobulin treatment in patients with hematological malignancies;International Journal of Technology Assessment in Health Care;2024

5. Secondary hypogammaglobulinemia in adults—A large retrospective cohort study;Medicina Clínica;2023-11